Peng He

1.3k total citations
49 papers, 989 citations indexed

About

Peng He is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Peng He has authored 49 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Peng He's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers) and RNA Interference and Gene Delivery (6 papers). Peng He is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers) and RNA Interference and Gene Delivery (6 papers). Peng He collaborates with scholars based in China, United States and Czechia. Peng He's co-authors include Jiahuai Han, Jianfeng Wu, Suqin Wu, Jianhui Ma, Yingying Zhang, Junming Ren, Zhentao Yang, Zhirong Zhang, Lanfen Chen and Wanze Chen and has published in prestigious journals such as Molecular Cell, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Peng He

48 papers receiving 982 citations

Peers

Peng He
Comparison fields: 5 of 110
  • Molecular Biology 592
  • Immunology 269
  • Cancer Research 205
  • Epidemiology 110
  • Oncology 103
Replace Yulin Xu with:
Yulin Xu China
Antonella Cecchettini Italy
Tong Su China
Jincheng Zeng China
Bo Shi China
Wei Shao China
Yuqi Zhao China
Haitao Gu China
Lin Wan China
Yulin Xu China View profile →
Citations per field, relative to Peng He
Peng He · 1×
Citations per year, relative to Peng He
Peng He · 1×

Countries citing papers authored by Peng He

Since Specialization
Citations

This map shows the geographic impact of Peng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng He more than expected).

Fields of papers citing papers by Peng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng He. The network helps show where Peng He may publish in the future.

Co-authorship network of co-authors of Peng He

This figure shows the co-authorship network connecting the top 25 collaborators of Peng He. A scholar is included among the top collaborators of Peng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng He. Peng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 1
3 1
4 1
5 2
6 16
7 27
8 57
9 15
10 28
11
microRNA-9 functions as a tumor suppressor in colorectal cancer by targeting CXCR4.
10
12 10
13 10
14 18
15 9
16
[Sequence analysis of VP1 region of coxsackievirus A4 and coxsackievirus A10 in Guangzhou city, 2010-2012].
1
17 27
18 27
19 48
20 362

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026